Cefixime

• Prime choice for switch therapy owing to its very good efficacy and safety profile.

• Lower MIC than cefaclor & ecfuroxime

Azithromycin

• Broad Spectrum Coverage
• Approved by CDS and US FDA.
• Broad Spectrum of actions against gram+ve & gram-ve organisms including H.influenzae
• Decreases mucus production in purulent rhinitis